Navigation Links
Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia
Date:3/21/2013

evaluate the safety and efficacy of OHR/AVR118 in advanced cancer patients with cachexia. Patients with stage III or IV solid tumors meeting the inclusion and exclusion criteria were enrolled and received daily subcutaneous injections of OHR/AVR118 for the treatment period (28 days).  The patients underwent weekly assessment visits to test for improvements in function, ability to complete daily tasks, weight and muscle mass measurements, and overall quality of life parameters. Patients who benefitted from the treatment could elect to continue receiving OHR/AVR118 during the extension period beyond the initial 28 day regimen. The study was conducted at two cancer centers under a HealthCanada IND.

About OHR/AVR118
OHR/AVR118 is a broad-spectrum peptide immunomodulator drug, which modulates cytokine action. The drug has shown a good safety profile in human clinical trials to date. The drug mitigates the deleterious effects of various pro-inflammatory cytokines that are implicated in the etiology of cachexia, whose activation has a direct effect on muscle metabolism and anorexia. OHR/AVR118 had been previously evaluated in clinical trials in over 70 AIDS cachexia patients, where it showed beneficial effects in mitigating multiple symptoms of the disease. Also completed with the drug was a 27 patient open label trial in rheumatoid arthritis.

About Cancer Cachexia
Cancer cachexia is the complex, multi-symptom syndrome in late-stage cancer patients, characterized by anorexia and unintended loss of appetite, progressive and continual weight loss, accompanied by generalized host tissue wasting, skeletal muscle atrophy, immune and metabolic dysfunction, and a greatly diminished quality of life. It is estimated that the market for cancer cachexia exceeds $ 1 billion globally. There is currently no FDA approved therapy for cancer cachexia.

About Ohr Pharmaceutical Inc.
Ohr Pharmaceutical Inc. (OTCQB: OHRP) is a pharmaceutical company dedi
'/>"/>

SOURCE Ohr Pharmaceutical
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Galderma, One of the Leading Pharmaceutical Companies, Relies on Verizon Enterprise Solutions to Provide Expanded, Secure Global Communications Platform
2. ENCO Pharmaceutical Development Announces Another Successful FDA Inspection - Its 2nd This Year
3. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
4. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
5. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
6. Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
7. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
8. National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research
9. Pharmaceutical Distribution Agreement Between Cardinal Health And Walgreens To End August 2013
10. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
11. Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of ... able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Device Industry, it steadfastly remains one of ... involving IP infringement. This litigious nature can ...
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ... Symphony® CGM System as a non-invasive, wireless continuous ... F. Doman , Executive Chairman and Interim CEO ... Financial Capital Markets, Tenth Annual Equity Conference. ... presentation to prospective corporate partners and investors at ...
(Date:1/15/2014)... , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ... Summary,Although the past decade has seen ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... , , LONDON , Jan. 28 ... Frost & Sullivan presents Japan Stent Technology with the 2009 European ... advancing localized drug delivery in the coronary care segment. The company ... device care that is witnessing a merging of device and pharmaceutical ...
... , ST. LOUIS , Jan. 27 ... received Section 510 (k) clearance from the U.S. Food and ... first ophthalmic device linking patients and doctors between eye exams ... a frequent but brief exam on their ForeseeHome AMD Monitor, ...
Cached Medicine Technology:Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design 2Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design 3Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design 4Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design 5Notal Vision's ForeseeHome(TM) AMD Monitor Receives FDA Clearance 2
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... bishops urged President-elect Barack Obama not to rescind ... care workers, prevent foreign aid to organizations promoting ... that encourages destruction of human embryos.They made the ... Francis George, President of the United States Conference ...
... Activator Online is the only authorized online ... 19 Known for bringing innovation to ... the industry,s only web-based seminar program dedicated ... Activator Online, the online learning system ...
... senior care marketplace is,booming, and so is the demand ... Americans. In response, SeniorCareMarketer.com has released a new,eBook designed ... the,competition. , The complimentary eBook ... Care Products and Convert Them to Leads" -- is ...
... Will Temper Losses Incurred by Leading Agents, According ... Jan. 19 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, despite ... the 2007-2017 forecast period, total sales for erectile ...
... hose clamps, the BFM® fitting to ensure new level of safety ... ... Chanhassen, MN (PRWEB) January 19, 2009 -- www.powder-solutions.com - ... will be sharing to attendees of the Northwest Food and Manufacturing ...
... among Peanut Corporation of America (PCA) brands of peanut butter across ... tainted peanut butter, which is expected to affect more Americans. ... ... the most comprehensive legal resource available on the Web, recently updated ...
Cached Medicine News:Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 2Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 3Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 4Health News:Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research 5Health News:Activator Methods Introduces Web-Based Seminar Program 2Health News:New eBook Helps Senior Care Suppliers Stand Out in Fast-Growing Marketplace 2Health News:Rapid Generic Erosion of Branded Agents, Including Market-Leading Viagra, Will Cause Sales of Erectile Dysfunction Drugs to Remain Flat Over the Next Decade 2Health News:Rapid Generic Erosion of Branded Agents, Including Market-Leading Viagra, Will Cause Sales of Erectile Dysfunction Drugs to Remain Flat Over the Next Decade 3Health News:Bulk Powder Processing Solution BFM Fitting on Display This Week at Northwest Food Manufacturing & Packaging Expo 2Health News:Bulk Powder Processing Solution BFM Fitting on Display This Week at Northwest Food Manufacturing & Packaging Expo 3Health News:LegalView Updates Peanut Butter Recall Information Portal with Info on Salmonella Contaminations Among Several Tainted Food Products 2Health News:LegalView Updates Peanut Butter Recall Information Portal with Info on Salmonella Contaminations Among Several Tainted Food Products 3Health News:LegalView Updates Peanut Butter Recall Information Portal with Info on Salmonella Contaminations Among Several Tainted Food Products 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: